Eli Lilly & Co.

NYS: LLY
Pharmaceuticals
Indianapolis IN
Title 1Chairman; President
Executive 1Dr. John C. Lechleiter, Ph.D., Chairman; President | Chairman; President
2015 Revenue (US$ Millions)$19,959
2014 Revenue (US$ Millions)$19,616
Revenue Growth (%)1.75%
Net Income (US$ Millions)$2,408
Common Shares Outstanding (Millions)$1,105
Earnings Per Share (US$)$2.26
Price To Earnings Ratio39.64
Total Equity (US$ Millions)$14,571
Return On Equity (%)15.67%
Long Term Debt (US$ Millions)$7,972
Debt To Equity Ratio (%)0.55%
Market Capitalization (US$ Millions)$93,130
Total Assets (US$ Millions)$35,569
Current Assets (US$ Millions)$12,574
Inventories (US$ Millions)$3,446
Current Liabilities (US$ Millions)$8,230
Cost of Goods Sold (US$ Millions)$5,037
Asset Turnover0.56
Inventory Turnover1.63